Study of lupus patients in Egypt
Part of Immune system & allergy, Skin clinical trials.
This study looks at the health information and background of people with lupus in Egypt, using existing medical records from 2016 to 2023. It helps doctors understand lupus better, but it does not test a new treatment or medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must have a diagnosis of lupus (SLE)
- You must have medical records from 2016 to 2023, with at least one year of follow-up
- You must be receiving routine care at a participating site
- You must not be newly diagnosed with lupus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the long-term health of people with lupus. It aims to understand how the disease progresses over time.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This study follows people with systemic lupus erythematosus (an autoimmune disease) who are seen in a special clinic. It aims to track their health over time.
This study looks at a type of immune cell in patients with active lupus. It may help doctors understand how lupus affects the immune system and could lead to better treatments.
This study looks at how lupus relates to “accelerated aging” and may help researchers better understand disease effects over time. You might be able to join if you have systemic lupus and are able to consent and participate.
This study tests whether a specific lupus “low disease activity” target (called LLDAS) works the same way in people across the Asia-Pacific region. It may help doctors use clearer goals to track how well lupus is controlled.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.